High Net Worth Advisory Group LLC Nuvalent, Inc. Transaction History
High Net Worth Advisory Group LLC
- $340 Million
- Q1 2025
A detailed history of High Net Worth Advisory Group LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, High Net Worth Advisory Group LLC holds 3,000 shares of NUVL stock, worth $214,920. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,000
Previous 3,000
-0.0%
Holding current value
$214,920
Previous $234,000
6.41%
% of portfolio
0.06%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding NUVL
# of Institutions
232Shares Held
57.8MCall Options Held
834KPut Options Held
490K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.29 Billion34.87% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.36MShares$384 Million16.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.5MShares$322 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$217 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.62MShares$188 Million6.84% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.08B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...